LABT Lakewood-Amedex Biotherapeutics Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:57
Sep 08
Sep 08
LABT short squeeze setup with presentation catalyst
Author argues LABT has a 1M float that has bottomed and is set up for a short squeeze, with zero shares available to borrow on IBKR, 700% cost to borrow, and 10% short interest. The stock was around $7+ a few weeks ago and the author believes it could surge toward $3+ as shorts cover and news brings volume. The stated catalyst is a presentation next week. Main risk is that the squeeze thesis depends on short covering materializing.
MED
About LABT Analyst Coverage
Buzzberg tracks LABT (Lakewood-Amedex Biotherapeutics Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: u/Living_Pin_9542.